Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Receivables - Net (2020 - 2023)

Immuneering (IMRX) has 4 years of Receivables - Net data on record, last reported at $1046.0 in Q1 2023.

  • For Q1 2023, Receivables - Net fell 99.63% year-over-year to $1046.0; the TTM value through Mar 2023 reached $1046.0, down 99.63%, while the annual FY2022 figure was $12417.0, 94.95% down from the prior year.
  • Receivables - Net reached $1046.0 in Q1 2023 per IMRX's latest filing, down from $12417.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $500110.0 in Q4 2020 and bottomed at $1046.0 in Q1 2023.
  • Average Receivables - Net over 4 years is $250479.1, with a median of $246040.0 recorded in 2021.
  • Peak YoY movement for Receivables - Net: tumbled 50.8% in 2021, then tumbled 99.63% in 2023.
  • A 4-year view of Receivables - Net shows it stood at $500110.0 in 2020, then crashed by 50.8% to $246040.0 in 2021, then tumbled by 94.95% to $12417.0 in 2022, then tumbled by 91.58% to $1046.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $1046.0 in Q1 2023, $12417.0 in Q4 2022, and $70180.0 in Q3 2022.